Last update:

Overweight & Obesity news

Medications

Novo Nordisk says US approves first GLP-1 pill for weight loss

Danish pharmaceutical giant Novo Nordisk announced Monday the US Food and Drug Administration (FDA) had approved its popular GLP-1 anti-obesity drug Wegovy to be administered in pill form for weight loss.

Health

Ozempic Meals? Restaurants shrink portions to match bite-sized hunger

A self-described foodie, social butterfly and New Yorker for 20 years, Lina Axmacher has long loved exploring the city's famed restaurant culture.

Overweight & Obesity

Ret finger protein: A hidden molecular switch that fuels obesity

Obesity is one of the greatest burdens of global public health. One major factor that drives obesity is excessive fat accumulation. Despite decades of research, the biological processes that trigger this abnormal fat accumulation ...

Overweight & Obesity

States retreat from covering drugs for weight loss

Some states are rethinking their coverage of GLP-1 drugs for weight loss as budgets tighten and Medicaid programs brace for the cuts included in President Donald Trump's broad tax and spending law.

Psychology & Psychiatry

One short quiz could help people stick to their weight loss plans

A new study, published in JMIR Formative Research, has found that people who answered a brief quiz to determine their "eating profile" were more likely to stick with their program and stay committed to their weight loss goals ...

Overweight & Obesity

COVID-19 pandemic linked to increases in childhood obesity

The COVID-19 pandemic not only disrupted children's education, recreation, and social lives, but it also increased the prevalence of obesity in the U.S. pediatric population by roughly 1 million youngsters, according to a ...

Alzheimer's disease & dementia

Blood test shows obesity speeds Alzheimer's development

Researchers have conducted the first study evaluating the impact of obesity on Alzheimer's disease blood biomarkers (BBMs). BBM values increased up to 95% faster in individuals with obesity than in non-obese individuals, ...

Overweight & Obesity

WHO backs GLP-1 treatments to tackle obesity epidemic

A range of blockbuster weight-loss and diabetes drugs could help shift the trajectory of the global obesity epidemic, which affects over one billion people worldwide, the World Health Organization said Monday.

Medications

WHO recommends Ozempic-style weight loss drugs for obesity

Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, relapsing disease associated with substantial morbidity, mortality, and economic burden.

Health

Study links America's favorite cooking oil to obesity

Soybean oil, the most widely consumed cooking oil in the United States and a staple of processed foods, contributes to obesity, at least in mice, through a mechanism scientists are now beginning to understand.

Psychology & Psychiatry

Binge-eating disorder not as transient as previously thought

Binge-eating disorder is the most prevalent eating disorder in the United States, but previous studies have presented conflicting views of the disorder's duration and the likelihood of relapse. A new five-year study led by ...

Overweight & Obesity

New study shows abdominal obesity and muscle weakness in 8-year-olds

The harmful combination of abdominal obesity and reduced muscle strength, also known as sarcopenic obesity, is already present in primary school children. This is shown by a new study among eight-year-olds, conducted at Karolinska ...

Medications

Wegovy could be treating more than obesity

A new analysis found that the profound benefits of Novo Nordisk's obesity drug Wegovy for people at risk of heart attacks or strokes don't depend on the number of the scale—cardiovascular health improves whether people ...

Overweight & Obesity

Low-income teens at higher risk of obesity: WHO

Teens from less affluent families in Europe are at greater risk of obesity, inactivity and poor diet, which are risk factors for cancer, cardiovascular disease and diabetes, the WHO said Thursday.

Cardiology

Video: Does intermittent fasting increase heart disease risk?

For years, people have used intermittent fasting to lose unwanted pounds, while others fast for religious reasons. The popular diet trend is generally safe, but some studies suggest that time-restricted eating could cause ...

Genetics

'Hungry gut' gene test shows who will benefit most from Wegovy

You've watched others shed pounds in a matter of weeks after taking one of the new blockbuster weight-loss drugs, so you decide to try one of the medications yourself, only to discover the needle on your bathroom scale barely ...

Neuroscience

Unique brain circuit is linked to body mass index

Why can some people easily stop eating when they are full and others can't, which can lead to obesity? A Northwestern Medicine study has found one reason may be a newly discovered structural connection between two regions ...